Antibody-drug conjugates

Kondengadan SM, Park Y, Byun H, Abdi R. Antibody-drug conjugates as immune modulators: current landscape, challenges, and opportunities. J Control Release. 2026 Nov 5:115526. doi:[...]

Margolis S, Kalbasi TR, Zektser Y, Niknafs A, Cui J, Lipsyc-Sharf MD, LeVee AA, Rugo HS, Bardia A, Sedrak MS. Efficacy and toxicity of antibody-drug[...]

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Moore H, Huppert LA, Moslehi JJ, Yang EH, Hatcher S, Thomas A. Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations:[...]

Jhaveri K, Anders CK, Bardia A, Bhave M, Chien AJ, Krop I, Traina TA, Abdou Y, Basho R, Conlin AK, Esteva FJ, Fox KR, Gadi[...]

Hendershot A, Slabaugh M, Riaz KM, Moore KN, O'Malley DM, Matulonis U, Konecny GE. Strategies for prevention and management of ocular events occurring with mirvetuximab[...]